...
首页> 外文期刊>Clinical drug investigation >Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials
【24h】

Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials

机译:铁缺乏症患者中铁羧糖和其他制剂的功效和安全性:随机对照试验的系统评价和网络Meta分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Iron deficiency is very common in a number of medical conditions. Ferric carboxymaltose is a new stable iron preparation that can be administered in single infusions over short periods of time. The aim of this study was to conduct a systematic review of randomised controlled trials (RCTs) regarding the efficacy and safety of the novel complex compared with other iron formulations. In addition, the feasibility of a network meta-analysis for indirect comparisons was investigated.
机译:背景铁缺乏症在许多医学状况中非常普遍。羧基麦芽糖铁是一种新型的稳定铁制剂,可在短时间内以单次输注的形式给药。这项研究的目的是对与其他铁制剂相比新型复合物的功效和安全性进行随机对照试验(RCT)的系统评价。此外,还研究了网络荟萃分析用于间接比较的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号